NPI: 1952771313 · TAMPA, FL 33607 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 09/29/2015
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 09/29/2015 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2019 | 13,845 | $1.58M |
| 2020 | 24,597 | $3.60M |
| 2021 | 6,781 | $613K |
| 2022 | 1,034 | $90K |
| 2023 | 215 | $52K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 13,869 | 961 | $1.94M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 14,431 | 596 | $1.46M |
| J1270 | Injection, doxercalciferol, 1 mcg | 8,359 | 498 | $1.06M |
| A4657 | Syringe, with or without needle, each | 2,702 | 764 | $606K |
| J1756 | Injection, iron sucrose, 1 mg | 2,640 | 404 | $263K |
| 83540 | 830 | 396 | $108K | |
| 83970 | 645 | 294 | $87K | |
| 85041 | 618 | 285 | $69K | |
| 85048 | 575 | 260 | $66K | |
| 83550 | 440 | 213 | $63K | |
| 82728 | 435 | 212 | $62K | |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 310 | 15 | $61K |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 346 | 88 | $43K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 214 | 110 | $28K |
| 82108 | 58 | 29 | $9K |